Global Antidiabetics Trends in 2024
Antidiabetics is part of Therapy and includes a number of sub-sectors such as Insulin. You may also be interested in Anesthetics, Anti-Infective and Cardiovascular Drug.
Global insulin exports are projected to decrease to approximately $7.17 billion by 2028, down from around $8 billion in 2023. This marks a 1% year-on-year compound annual growth rate (CAGR). Despite this anticipated decline, global supply has seen a steady increase of 2.1% annually since 2019. Leading the charge in insulin exports in 2023 is Germany, boasting an impressive $3.58 billion in exports. Trailing Germany, France, Italy, and China secured the second, third, and fourth positions, respectively, in the global insulin export rankings. Meanwhile, Chile has made significant strides, with its exports surging by 77.5% year-on-year. In stark contrast, Japan's insulin exports have plummeted by 21.4% annually since 2019.
Top 8 countries
In 2024 major markets in the Antidiabetics Industry were:
World Antidiabetics Market Data and Forecasts
How much the Antidiabetics industry is expected to grow to 2028?
World Antidiabetics Top Rankings
Global Antidiabetics Statistics
- Insulin Import 183 countries (Africa, Asia, Sub-Saharan Africa...)
- Pharmaceutical Imports 193 countries (Africa, Sub-Saharan Africa, Latin America...)
- Insulin Export 108 countries (Europe, Asia, Africa...)
- Pharmaceutical Exports 190 countries (Asia, Latin America, Africa...)
- Hormones Sales 49 countries (Europe, Northern Europe, Southern Europe...)
- Diabetes Medicine Sales 43 countries (Europe, Northern Europe, Southern Europe...)
- Medicine Use 130 countries (Europe, Northern Europe, Southern Europe...)
- Herbicide Import 189 countries (Africa, Sub-Saharan Africa, Europe...)
- Herbicide Export 152 countries (Europe, Latin America, Africa...)
- Herbicide Sales 57 countries (Europe, Southern Europe, Western Europe...)
